Vitasora Health Limited
VHLUF
$0.0581
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 485.16% | 491.61% | 494.26% | 217.63% | 59.32% |
| Total Other Revenue | 6.34% | 2.82% | -3.55% | -3.55% | -3.55% |
| Total Revenue | 135.35% | 100.17% | 53.00% | 29.49% | 7.93% |
| Cost of Revenue | 1,160.38% | 246.13% | -94.56% | -92.83% | -92.46% |
| Gross Profit | 103.01% | 90.43% | 69.18% | 75.59% | 85.98% |
| SG&A Expenses | 30.28% | 31.23% | 30.35% | 26.39% | 23.27% |
| Depreciation & Amortization | -96.16% | -66.67% | -19.81% | 15.34% | 48.66% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.10% | 28.67% | 22.90% | 9.58% | -1.68% |
| Operating Income | -19.29% | -20.16% | -19.46% | -7.34% | 2.75% |
| Income Before Tax | -17.84% | -19.77% | -20.24% | -8.44% | 1.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.84% | -19.77% | -20.24% | -8.44% | 1.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.84% | -19.77% | -20.24% | -8.44% | 1.41% |
| EBIT | -19.29% | -20.16% | -19.46% | -7.34% | 2.75% |
| EBITDA | -20.39% | -20.35% | -18.67% | -6.52% | 3.48% |
| EPS Basic | 14.29% | 12.24% | 6.25% | 9.62% | 14.04% |
| Normalized Basic EPS | 13.33% | 10.00% | 6.67% | 12.12% | 16.67% |
| EPS Diluted | 10.20% | 8.16% | 2.08% | 7.69% | 14.04% |
| Normalized Diluted EPS | 13.33% | 10.00% | 6.67% | 12.12% | 16.67% |
| Average Basic Shares Outstanding | 34.76% | 30.63% | 26.19% | 20.65% | 14.76% |
| Average Diluted Shares Outstanding | 34.76% | 30.63% | 26.19% | 20.65% | 14.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |